1.            Stein-Zamir, C., Abramson, N., Sokolov, I., Mor-Shimshi, L. & Shoob, H. Case Ascertainment of Measles during a Large Outbreak—Laboratory Compared to Epidemiological Confirmation. Diagnostics 14, (2024).

2.            Alshech, R., Shoob, H. & Stein-Zamir, C. Hospitalizations and Clinical Severity of COVID-19 among Infants under 1-Year-old. Pediatr. Infect. Dis. J. 42, E400–E402 (2023).

3.            Stein-Zamir, C., Shoob, H., Abramson, N., Brown, E. H. & Zimmermann, Y. Pertussis outbreak mainly in unvaccinated young children in ultra-orthodox Jewish groups, Jerusalem, Israel 2023. Epidemiol. Infect. 151, (2023).

4.            Stein-Zamir, C. et al. Invasive Disease Due to Neisseria meningitidis: Surveillance and Trends in Israel Prior to and during the COVID-19 Pandemic. Microorganisms 11, (2023).

5.            Stein-Zamir, C., Shoob, H. & Abramson, D. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak. Vaccine 41, 2764–2768 (2023).

6.            Kochav-Lev, M., Bennett-Back, O., Lotan, M. & Stein-Zamir, C. The Use of the Alberta Infant Motor Scale (AIMS) as a Diagnostic Scale for Infants with Autism. Diagnostics 13, (2023).

7.            Saidu, Y. et al. The Hidden Impact of the COVID-19 Pandemic on Routine Childhood Immunization Coverage in Cameroon. Vaccines 11, (2023).

8.            Stein-Zamir, C. et al. SARS-CoV-2 infection characteristics among students and staff in a large high school COVID-19 outbreak and secondary transmission in households. Infect. Med. 2, 36–43 (2023).

9.            Gordon-Shaag, A. et al. Adherence to referrals from preschool vision screening and identification of barriers for non-adherence in Israel. Clin. Exp. Optom. 106, 202–210 (2023).

10.          Nchinjoh, S. C. et al. Factors Associated with Zero-Dose Childhood Vaccination Status in a Remote Fishing Community in Cameroon: A Cross-Sectional Analytical Study. Vaccines 10, (2022).

11.          Zimmerman, D. R. et al. Breastfeeding challenges and support in a high initiation population. Isr. J. Health Policy Res. 11, (2022).

12.          Gadassi, H. et al. Enhancing the primary care pediatrician’s role in managing psychosocial issues: a cross sectional study of pediatricians and parents in Israel. Isr. J. Health Policy Res. 11, (2022).

13.          Zahran, S., Nir-Paz, R., Paltiel, O., Stein-Zamir, C. & Oster, Y. Are Healthcare Workers Infected with SARS-CoV-2 at Home or at Work? A Comparative Prevalence Study. Int. J. Environ. Res. Public Health 19, (2022).

14.          Ekezie, W. et al. Access to Vaccination among Disadvantaged, Isolated and Difficult-to-Reach Communities in the WHO European Region: A Systematic Review. Vaccines 10, (2022).

15.          Stein, M. et al. Project Report The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines 10, (2022).

16.          Stein-Zamir, C. & Rishpon, S. The National Immunization Technical Advisory Group in Israel. Isr. J. Health Policy Res. 10, (2021).

17.          Stein-Zamir, C. et al. Utilization of the Public Health Ordinance to prevent nosocomial spread in a case of acute measles-associated psychosis. Isr. J. Health Policy Res. 10, (2021).

18.          Lavi, E. et al. Eligibility for growth hormone therapy in children born small for gestational age is substantially lower than expected. Clin. Endocrinol. (Oxf). 95, 308–314 (2021).

19.          Stein-Zamir, C., Verbov, G., Polak, R. & Constantini, N. Hadassah Optimal: Exercise and nutrition in the immediate postpartum period in Israel-a successful intervention accompanied by government adoption. in Peace Building Through Women’s Health: Psychoanalytic, Sociopsychological, and Community Perspectives on the Israeli-Palestinian Conflict 109–125 (Taylor and Francis, 2021). doi:10.4324/9781003163657-8.

20.          Bary-Weisberg, D. & Stein-Zamir, C. Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study. Hum. Vaccines Immunother. 17, 1666–1674 (2021).

21.          Paltiel, O. et al. Academic activism on behalf of children during the COVID-19 pandemic in Israel; beyond public health advocacy. Isr. J. Health Policy Res. 10, (2021).

22.          Stein-Zamir, C., Israeli, A. & Grotto, I. Immunization registry as a digital assessment tool during outbreaks. Clin. Microbiol. Infect. 27, 166–168 (2021).

23.          Stein-Zamir, C. & Levine, H. The measles outbreak in Israel in 2018-19: lessons for COVID-19 pandemic. Hum. Vaccines Immunother. 17, 2085–2089 (2021).

24.          Stein-Zamir, C. et al. A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020. Eurosurveillance 25, (2020).

25.          Stein-Zamir, C., Abramson, N. & Shoob, H. Large measles outbreak in orthodox jewish communities - Jerusalem district, Israel, 2018-2019. Morb. Mortal. Wkly. Rep. 69, 562–563 (2020).

26.          Ben-Chetrit, E. et al. Measles-related hospitalizations and associated complications in Jerusalem, 2018–2019. Clin. Microbiol. Infect. 26, 637–642 (2020).

27.          Kaplan, M., Zimmerman, D., Shoob, H. & Stein-Zamir, C. Post-discharge neonatal hyperbilirubinemia surveillance. Acta Paediatr. Int. J. Paediatr. 109, 923–929 (2020).

28.          Amitai, Y., Shental, H., Atkins-Manelis, L., Koren, G. & Zamir, C. S. Pre-conceptional folic acid supplementation: A possible cause for the increasing rates of ankyloglossia. Med. Hypotheses 134, (2020).

29.          Zimmerman, D. R. et al. Evidence-based preschool-age vision screening: Health policy considerations. Isr. J. Health Policy Res. 8, (2019).

30.          Stein-Zamir, C., Sokolov, I., Abramson, N. & Shoob, H. Pertussis Outbreak in Infants and an Immunization Campaign Based on Providing Pertussis Vaccine Doses at 6 Weeks, 10 Weeks, and 14 Weeks. Pediatr. Infect. Dis. J. 38, E63–E64 (2019).

31.          Zimmerman, D. R., Verbov, G., Edelstein, N. & Stein-Zamir, C. Preventive health services for young children in Israel: Historical development and current challenges. Isr. J. Health Policy Res. 8, (2019).

32.          Stein-Zamir, C. et al. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Hum. Vaccines Immunother. 15, 242–248 (2019).

33.          Stein-Zamir, C. et al. Community-oriented epidemic preparedness and response to the Jerusalem 2018–2019 measles epidemic. Am. J. Public Health 109, 1714–1716 (2019).

34.          Stein-Zamir, C. & Israeli, A. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel. Eurosurveillance 24, (2019).

35.          Hasson, R. et al. ‘Practice What You Teach’ Public Health Nurses Promoting Healthy Lifestyles (PHeeL-PHiNe): Program Evaluation. J. Ambul. Care Manage. 41, 171–180 (2018).

36.          Stein-Zamir, C., Shoob, H. & Zimmerman, D. R. The role of the physician in Israel’s maternal child health clinics: Surveys of professional and parental perceptions. Isr. J. Health Policy Res. 6, (2017).

37.          Stein-Zamir, C. & Israeli, A. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel. Hum. Vaccines Immunother. 13, 2102–2110 (2017).

38.          Indenbaum, V. et al. Ongoing mumps outbreak in Israel, January to August 2017. Eurosurveillance 22, (2017).

39.          Stein Zamir, C. & Israeli, A. Knowledge, Attitudes and Perceptions About Routine Childhood Vaccinations Among Jewish Ultra-Orthodox Mothers Residing in Communities with Low Vaccination Coverage in the Jerusalem District. Matern. Child Health J. 21, 1010–1017 (2017).

40.          Ginsberg, G. M., Block, C. & Stein-Zamir, C. Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel. Int. J. Public Health 61, 683–692 (2016).

41.          Valinsky, L. et al. A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone. Epidemiol. Infect. 144, 183–188 (2016).

42.          Zimmerman, D. R., Amitai, Y., Grossman, Z. & Stein-Zamir, C. Referral patterns of Israeli pediatricians of common primary care office procedures. Isr. J. Health Policy Res. 4, (2015).

43.          Polak, R. et al. Public Health Nurses Promoting Healthy Lifestyles (PHeeL-PHiNe): Methodology and Feasibility. J. Ambul. Care Manage. 38, 164–177 (2015).

44.          Zamir, C. S., Dahan, D. B. & Shoob, H. Pertussis in infants under one year old: Risk markers and vaccination status-A case-control study. Vaccine 33, 2073–2078 (2015).

45.          Stein Zamir, C., Schroeder, H., Shoob, H., Abramson, N. & Zentner, G. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum. Vaccines Immunother. 11, 1413–1417 (2015).

46.          Olshtain-Pops, K. et al. Association of HIV and syphilis seropositivity with transit stay in urban areas among Ethiopian immigrants to Israel. Isr. Med. Assoc. J. 16, 427–430 (2014).

47.          Stein-Zamir, C. et al. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr. Infect. Dis. J. 33, 777–779 (2014).

48.          Adler, A. et al. Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel. J. Clin. Microbiol. 51, 2926–2930 (2013).

49.          Sharf, M. et al. Erratum to ‘Figuring out food labels: Young adults’’ understanding of nutritional information presented on food labels is inadequate" [Appetite 58 (2012) 531-534]’. Appetite 59, 617 (2012).

50.          Stein-Zamir, C., Shoob, H., Abramson, N. & Zentner, G. Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol. Infect. 140, 1578–1588 (2012).

51.          Daudi, N., Shouval, D., Stein-Zamir, C. & Ackerman, Z. Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. Breastfeed. Med. 7, 313–315 (2012).

52.          Knishkowy, B., Verbov, G., Amitai, Y., Stein-Zamir, C. & Rosen, L. Reaching Jewish ultra-orthodox adolescents: Results from a targeted smoking prevention trial. Int. J. Adolesc. Med. Health 24, 173–179 (2012).

53.          Sharf, M. et al. Figuring out food labels. Young adults’ understanding of nutritional information presented on food labels is inadequate. Appetite 58, 531–534 (2012).

54.          Stein-Zamir, C., Zentner, G., Tallen-Gozani, E., Grotto, I. & Gamzu, R. The national childhood immunization registry in Israel. Procedia Vaccinol. 4, 9–13 (2011).

55.          Stein-Zamir, C., Shoob, H., Abramson, N. & Zentner, G. The impact of additional pertussis vaccine doses on disease incidence in children and infants. Vaccine 29, 207–211 (2010).

56.          Geal-Dor, M., Adelman, C., Levi, H., Zentner, G. & Stein-Zamir, C. Comparison of two hearing screening programs in the same population: Oto-acoustic emissions (OAE) screening in newborns and behavioral screening when infants. Int. J. Pediatr. Otorhinolaryngol. 74, 1351–1355 (2010).

57.          Stein-Zamir, C. The authors reply. Epidemiol. Infect. 138, 1406 (2010).

58.          Cohen, H. et al. Israeli guidelines for the management of hypercholesterolemia in children and adolescents. Report of the pediatric association expert group. e-SPEN 5, e132–e143 (2010).

59.          Stein-Zamir, C., Zentner, G., Tallen-Gozani, E. & Grotto, I. The Israel national immunization registry. Isr. Med. Assoc. J. 12, 296–300 (2010).

60.          Stein-Zamir, C. et al. Salmonella enterica outbreak in a banqueting hall in Jerusalem: The unseen hand of the epidemiological Ttriangle? Isr. Med. Assoc. J. 11, 94–97 (2009).

61.          Stein-Zamir, C., Shoob, H., Abramson, N., Zentner, G. & Agmon, V. The changing panorama of bacterial enteric infections. Epidemiol. Infect. 137, 1531–1537 (2009).

62.          Stein-Zamir, C. et al. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill. 14, (2009).

63.          Stein-Zamir, C., Shoob, H., Nubani, N. & Zentner, G. Hepatitis A in Jerusalem-The exception that proves the rule? Vaccine 26, 5241–5243 (2008).

64.          Stein-Zamir, C., Volovik, I., Rishpon, S. & Sabi, R. Developmental dysplasia of the hip: Risk markers, clinical screening and outcome. Pediatr. Int. 50, 341–345 (2008).

65.          Stein-Zamir, C. et al. Invasive meningococcal disease in children in Jerusalem. Epidemiol. Infect. 136, 782–789 (2008).

66.          Stein-Zamir, C. et al. Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem. Epidemiol. Infect. 136, 207–214 (2008).

67.          Stein-Zamir, C., Abramson, N., Shoob, H. & Zentner, G. An outbreak of measles in an ultra-orthodox Jewish community in Jerusalem, Israel, 2007--an in-depth report. Euro Surveill. 13, (2008).

68.          Singer, S. R. et al. Ecoepidemiology of cutaneous leishmaniasis outbreak, Israel. Emerg. Infect. Dis. 14, 1424–1426 (2008).

69.          Stein-Zamir, C., Volovik, I. & Rishpon, S. Control of Hepatitis A outbreaks in an endemic community: the role of sustained immunization coverage. Public Health 121, 199–201 (2007).

70.          Chemtob, D., Sasson, M., Leventhal, A., Stein-Zamir, C. & Maayan, S. Sexually transmitted infections among individuals with and without HIV [1]. Isr. Med. Assoc. J. 8, 892 (2006).

71.          Stein-Zamir, C. et al. Tuberculosis outbreak among students in a boarding school. Eur. Respir. J. 28, 986–991 (2006).

72.          Rorman, E., Zamir, C. S., Rilkis, I. & Ben-David, H. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reprod. Toxicol. 21, 458–472 (2006).

73.          Zamir, D. et al. Nosocomial infections in internal medicine departments. Harefuah 142, 265-268+318 (2003).

74.          Zamir, D. et al. Fever of unknown origin in Israel. Acta Clin. Belg. 58, 356–359 (2003).

75.          Zamir, D. et al. Diarrhea and hypokalemia as primary manifestations of medullary carcinoma of the thyroid [1]. Am. J. Med. 113, 438–439 (2002).

76.          Mumcuoglu, K. Y. et al. The in vivo pediculicidal efficacy of a natural remedy. Isr. Med. Assoc. J. 4, 790–793 (2002).

77.          Zamir, D., Storch, S., Kovach, I., Storch, R. & Zamir, C. Early detection of hepatic encephalopathy by recording visual evoked potential (VEP). Rocz. Akad. Med. w Białymstoku 47, 186–193 (2002).

78.          Zamir, D., Zamir, C. & Rishpon, S. Epidemiology of hepatitis B virus infection among family members of chronic carriers in Israel. Isr. Med. Assoc. J. 3, 338–340 (2001).

79.          Zamir, D., Zamir, C., Weinstein, T. & Gafter, U. Hepatitis C infection in dialysis patients in Israel (multiple letters). Isr. Med. Assoc. J. 3, 551 (2001).

80.          Zamir, C. et al. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine. Eur. J. Clin. Microbiol. Infect. Dis. 20, 185–187 (2001).

81.          Zamir, C., Zamir, D., Rishpon, S. & Spencer, N. Traditional practices among children of Ethiopian immigrants in Israel. Ambul. Child Heal. 5, 351–356 (1999).

82.          Zamir, D., Shtorch, S., Zamir, C., Fireman, Z. & Zonder, H. Low prevalence of hepatitis G infection in dialysis patients. Harefuah 137, 361–363 (1999).

83.          Zamir, D., Weizman, J., Zamir, C., Fireman, Z. & Weiner, P. Mesalamine-induced hypersensitivity pneumonitis. Harefuah 137, 28–87 (1999).

84.          Zamir, D. et al. Severe jaundice in a gunshot casualty due to the coexistence of Dubin- Johnson and glucose-6-phosphate dehydrogenase deficiency. J. Clin. Gastroenterol. 28, 383–385 (1999).

85.          Zamir, D., Zamir, C., Storch, S., Litmanovich, M. & Weiner, P. Acute malaria in an Israeli tourist to Kenya. Harefuah 136, 545-546,587 (1999).

86.          Zamir, C. et al. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen- positive/hepatitis B e antigen-negative carriers. Pediatr. Infect. Dis. J. 18, 262–266 (1999).

87.          Zamir, D., Storch, S., Zonder, H. B., Zamir, C. & Weiner, P. Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis. J. Clin. Gastroenterol. 28, 23–28 (1999).

88.          Zamir, D., Zamir, C. & Weiner, P. Hepatitis C, therapy and predicting factors. Harefuah 132, 643–648 (1997).

89.          Zamir, D., Zamir, C. & Weiner, P. New hepatotoxic viruses. Harefuah 132, 338–341 (1997).

90.          Zamir, D., Zamir, C. & Weiner, P. Acute fulminant hepatitis. Harefuah 132, 34–39 (1997).

91.          Regev, R., Dolfin, T. & Zamir, C. Multiple brain abscesses in a premature infant: complication of Staphylococcus aureus sepsis. Acta Pædiatrica 84, 585–587 (1995).

92.          Dolfin, T., Zamir, C., Regev, R., Ari, J. B. & Wolach, B. Effect of surfactant replacement therapy on the outcome of premature infants with respiratory distress syndrome. Isr. J. Med. Sci. 30, 267–270 (1994).

93.          Zamir, C., Qivity, S., Heldenberg, D. & Topilsky, M. Adverse drug effects in bronchial asthma. Harefuah 119, 392–396 (1990).

94.          Zamir, C., Abudi, Z. & Yurman, S. Surfactant for the treatment of respiratory distress syndrome. Harefuah 117, 399–404 (1989).